Leukocyte glucocerebrosidase and β-hexosaminidase activity in sporadic and genetic Parkinson disease

Parkinsonism and Related Disorders

Volumn 23, Issue , 2016, Pages 99-101

  Kim, Han Joon ^a   Jeon, Beomseok ^a   Song, Junghan ^b,c   Lee, Woong Woo ^d   Park, Hyeyoung ^a   Shin, Chae Won ^a  

^a Seoul National University   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

^d Eulji General Hospital   (South Korea)

Author keywords

Gaucher disease; Leukocyte; Parkinson disease; Glucocerebrosidase; hexosaminidase

Indexed keywords

BETA N ACETYLHEXOSAMINIDASE; BIOLOGICAL MARKER; GLUCOSYLCERAMIDASE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; ENZYME ACTIVITY; ENZYME ANALYSIS; GENE; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; LEUKOCYTE; PARK2 GENE; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; SPINOCEREBELLAR DEGENERATION; BLOOD; ENZYMOLOGY; GENETICS;

BETA-N-ACETYLHEXOSAMINIDASES; BIOMARKERS; GLUCOSYLCERAMIDASE; HUMANS; LEUKOCYTES; PARKINSON DISEASE;

EID: 84954289425     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2015.12.002     Document Type: Article

References (12)

1. Siebert M., Sidransky E., Westbroek W. Glucocerebrosidase is shaking up the synucleinopathies. Brain 2014, 137:1304-1322.
2. Mazzulli J.R., Xu Y.-H., Sun Y., et al. Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell 2011, 146:37-52.
3. Gegg M.E., Burke D., Heales S.J., et al. Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains. Ann. Neurol. 2012, 72:455-463.
4. Parnetti L., Chiasserini D., Persichetti E., et al. Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's disease. Mov. Disord. 2014, 29:1019-1027.
5. Nuzhnyi E., Emelyanov A., Boukina T., et al. Plasma oligomeric alpha-synuclein is associated with glucocerebrosidase activity in Gaucher disease. Mov. Disord. 2015, 30:989-991.
6. Murphy K.E., Gysbers A.M., Abbott S.K., et al. Reduced glucocerebrosidase is associated with increased alpha-synuclein in sporadic Parkinson's disease. Brain 2014, 137:834-848.
7. McNeill A. Is elevated beta-hexosaminidase activity a potential biomarker for Parkinson's disease?. Mov. Disord. 2014, 29:1328-1329.
8. Shapira E., Blitzer M., Miller J., Africk D.K. Biochemical Genetics. A Laboratory Manual 1989, 1-46. Oxford University Press, New York. first ed.
9. Alcalay R.N., Levy O.A., Waters C.H., et al. Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations. Brain 2015, 138:2648-2658.
10. Kim S., Jeon B.S., Heo C., et al. α-synuclein induces apoptosis by altered expression in human peripheral lymphocyte in Parkinson's disease. FASEB J. 2004, 18:1615-1617.
11. Brighina L., Prigione A., Begni B., et al. Lymphomonocyte alpha-synuclein levels in aging and in Parkinson disease. Neurobiol. Aging 2010, 31:884-885.
12. Duran R., Mencacci N.E., Angeli A.V., et al. The glucocerobrosidase E326K variant predisposes to Parkinson's disease, but does not cause Gaucher's disease. Mov. Disord. 2013, 28:232-236.